Researchers dealing with targeted nanomedicines and nuclear sciences have developed various strategies to exploit the potential of GRPR targeting with nanoformulations aiming at either cancer treatment, imaging, and diagnosis, or the combination of those two modalities. The gene discussed is GRPR; the disease is cancer.